3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
21
Recurrence
8
Lymphoma, Large B-Cell, Diffuse
7
Leukemia, Myeloid, Acute
4
Sarcoma
3
Endometrial Neoplasms
3
Primary Myelofibrosis
2
Neurofibrosarcoma
2
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell
2
Glioblastoma
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Vascular Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Triple Negative Breast Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Interventions
pembrolizumab
25
Cisplatin
20
Carboplatin
14
Paclitaxel
11
Radiotherapy
9
Radiotherapy, Intensity-Modulated
8
Docetaxel
8
Cetuximab
8
Nivolumab
6
cemiplimab
5
Radiation
5
durvalumab
4
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Fluorouracil
3
Drug Therapy
3
Cyclophosphamide
3
Blood Specimen Collection
3
toripalimab
2
olaparib
2
fludarabine
2
avelumab
2
alpha-2'-deoxythioguanosine
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
selinexor
×
1 year
×
Clear all
No trials found.